TSCV Thrivent Small Cap Value ETF

Expense Ratio
0.6%
Dividend
0.25%
Previous close
$29.64
Est. 12 months change
+32.46%
Projected Price
$39.26

Profitability Metrics

Return on Equity (ROE)
8.14%
Return on Assets (ROA)
5.13%
Return on Invested Capital (ROIC)
9.91%
Weighted Average Cost of Capital (WACC)
7.96%
ROIC - WACC
1.94%
Updated : 2026-09-28 18:24 ET

Valuation Metrics

P/E Ratio
14.80
Forward P/E
12.13
PEG Ratio
1.40
Debt Current Ratio
2.01

Growth & Cash Flow

Gross Margin
39.36%
Operating Margin
7.07%
FCF Margin
15.18%
TTM Revenue Growth
15.28%
Projected 12M EPS Growth
22.02%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NA3.58%
UMBF2.86%
VLY2.53%
ASH2.48%
AUB2.47%
ONB2.47%
KFY2.45%
WTFC2.44%
CWK2.37%
AAP2.19%

ETF Analysis

Fund Overview

Thrivent Small Cap Value ETF (TSCV) currently reports 57 stock positions (subject to change), placing it in the moderately diversified range by holdings breadth. The top line-up is NA (3.58%), UMBF (2.86%), VLY (2.53%), with NA as the largest single weight at 3.58%. Together, the top three holdings account for 8.97%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 9.91%, WACC is 7.96%, and the economic spread is 1.94%. On balance, holdings marginally exceed their cost of capital, suggesting modest but present value creation. Supporting metrics show ROE at 8.14% and ROA at 5.13%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

Multiple analysis puts the portfolio at trailing P/E of 14.80, forward P/E of 12.13, PEG of 1.40. Trailing and forward multiples are nearly identical, indicating the market is pricing the portfolio on a relatively static earnings assumption. Growth-adjusted, the portfolio looks reasonably valued — the PEG ratio implies the market is not extrapolating the growth narrative aggressively. At 2.01, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The combined valuation and liquidity profile points to a portfolio where current prices embed meaningful growth expectations, and where delivery against those expectations will drive the return outcome.

Margins & Cash Generation

On the margin front: gross margin sits at 39.36%, operating margin at 7.07%, and free cash flow margin at 15.18%. At this level, gross margins suggest a more competitive or capital-intensive operating environment across the holdings. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 15.28% reflecting consistent if unspectacular revenue expansion. Consensus EPS estimates point to 22.0% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations point to meaningful upside if execution holds on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.